Home › Calculator › HUMA Dividend Calculator 2026
HUMA Dividend DRIP Calculator 2026
281.69% YieldHealthcareHumacyte, Inc. · NASDAQ
Price: $0.71 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When HUMA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your HUMA snowball 📈
$10,000 in HUMA → $15480762181967234.00M in 10 years · $1,289,616,431,342,523,500,000.00/month
About Humacyte, Inc. (HUMA) — Dividend Analysis 2026
Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs). These investigational HAVs are specifically crafted for universal compatibility, enabling easy implantation into any patient without inducing an immune rejection or an adverse foreign body response. Humacyte is currently building a pipeline of HAVs targeting the substantial market for vascular repair, reconstruction, and replacement. This includes applications such as treating vascular trauma, providing arteriovenous access for hemodialysis, addressing peripheral arterial disease, and facilitating coronary artery bypass grafting. Furthermore, the company is exploring the use of its HAVs for pediatric heart surgeries and for cellular therapeutic delivery, including the transplantation of pancreatic islet cells to manage Type 1 diabetes. Founded in 2004, Humacyte maintains its headquarters in Durham, North Carolina.
Compare HUMA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HUMA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HUMA position with:
🌍 HUMA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HUMA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 281.69% | 278.89% | $28,169 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 239.44% | 236.64% | $23,944 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 225.35% | 222.55% | $22,535 / yr |
| 🇬🇧 UK ISA | 0% | 281.69% | 278.89% | $28,169 / yr |
| 🇬🇧 UK Taxable | 8.75% | 257.04% | 254.24% | $25,704 / yr |
| 🇨🇦 TFSA | 0% | 281.69% | 278.89% | $28,169 / yr |
| 🇨🇦 CA Taxable | 25% | 211.27% | 208.47% | $21,127 / yr |
| 🇦🇺 Super (pension) | 15% | 239.44% | 236.64% | $23,944 / yr |
| 🇦🇺 AU Taxable | 30% | 197.18% | 194.38% | $19,718 / yr |
| 🇩🇪 DE Taxable | 26.375% | 207.39% | 204.59% | $20,739 / yr |
| 🇫🇷 FR Taxable | 30% | 197.18% | 194.38% | $19,718 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HUMA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HUMA Dividend Payment Schedule
HUMA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 HUMA vs Healthcare Benchmarks
How HUMA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HUMA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HUMA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K | ||
| A-Award | 2026-06-11 | 80,000 | $1.08 | $86.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HUMA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Humacyte, Inc. (HUMA) is currently trading at $0.71, 96% below its 52-week high. The current dividend yield is 281.69% based on an annual payout of $2.00 per share.
HUMA (Humacyte, Inc.) — 281.69% Dividend Yield Analysis
Humacyte, Inc. (HUMA) is a healthcare stock currently trading at $0.71 with a dividend yield of 281.69%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (281.69%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.